Profiel
Charbel Helaihel worked as the VP-Marketing & Commercial Planning at Inhibrx, Inc. from 2023 to 2024.
He completed his undergraduate degree at Beirut Arab University.
Eerdere bekende functies van Charbel Helaihel
| Bedrijven | Functie | Einde |
|---|---|---|
| INHIBRX, INC. | Verkoop & Marketing | 30-05-2024 |
Opleiding van Charbel Helaihel
| Beirut Arab University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
